Physician profile
Aimee M Mitchell
NPI 1578784013
$1,016.55
in general payments reported to CMS, 2019-2025
12 companies · $364 in 2025
The $364 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $163 · 2022: $81.71 · 2023: $105 · 2024: $302 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $772.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $771.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $281.43 | 2021-2025 | |
| Genzyme Corporation | $186.98 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $160.23 | 2023-2025 | Dupixent, Libtayo |
| Arcutis Biotherapeutics, INC. | $85.65 | 2023-2025 | Zoryve |
| Ucb, INC. | $78.46 | 2024-2025 | Bimzelx |
| Pfizer INC. | $55.36 | 2021-2022 | |
| Janssen Biotech, INC. | $35.29 | 2021-2023 | Stelara, Remicade, Simponi |
| Sun Pharmaceutical Industries INC. | $32.92 | 2023-2024 | Absorica Ld, Winlevi |
| Almirall LLC | $28.25 | 2025 | Seysara |
| Dermavant Sciences, INC. | $24.54 | 2024 | Vtama |
| Organon LLC | $23.90 | 2025 | Vtama |
| Medimetriks Pharmaceuticals, INC. | $23.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aimee Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.